HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Vesper, H. W. Articles by Myers, G. L. Search for Related Content PubMed PubMed Citation Articles by Vesper, H. W. Articles by Myers, G. L. Related Collections Proteomics and Protein Markers Endocrinology and Metabolism

Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline

¹ Centers for Disease Control and Prevention, Atlanta, GA 30341-3724.

² Milton S. Hershey Medical Center, Hershey, PA 17033.

³ Northern General Hospital, Sheffield S5 7AU, United Kingdom.

⁴ INSERM Research Unite 403 & Synarc, F-69003 Lyon, France.

⁵ Wayne State University, Detroit, MI 48201.

⁶ The Rowett Research Institute, Aberdeen AB21 9SB, United Kingdom.

⁷ J.L. Pettis Veterans’ Affairs Medical Center, Loma Linda, CA 92357.

⁸ Pacific BioMetrics Research Foundation, Issaquah, WA 98027.

⁹ Emory University, Atlanta, GA 30322.

^aAuthor for correspondence. Fax 770-488-4192; e-mail hav2{at}cdc.gov.

Background: Pyridinoline (PYD) and deoxypyridinoline (DPD) are two of the most extensively characterized biochemical bone markers, but the interpretation of results is hampered by biologic and other preanalytical variability. We reviewed factors contributing to preanalytical variation of pyridinium cross-links in urine.

Methods: We searched four databases for English-language reports on PYD and/or DPD in urine. Searches were restricted to humans, except for studies of stability, when the search was expanded to other species. The 599 identified articles were supplemented with references from those articles and with articles known to the authors.

Results: The mean reported within-day variability was 71% for PYD (range, 57–78%) and 67% for DPD (range, 53–75%). The mean interday variability was 16% for both DPD and PYD (range for PYD, 12–21%; range for DPD, 5–24%). The mean intersubject variabilities across studies were 26% for PYD (range, 12–63%) and 34% for DPD (range, 8–98%) for healthy premenopausal women and 36% (range, 22–61%) and 40%, (range, 27–54%) for postmenopausal women, respectively. Specimen instability and errors in creatinine measurements were additional sources of variability.

Conclusions: Intra- and intersubject variability can be reduced by collecting specimens at a specific time of the day and by maintaining similar patient status at each specimen collection regarding factors such as medications and dietary supplements.

The following articles in journals at HighWire Press have cited this article:

				M. Di Stefano, F. Formoso, C. Tamone, G. Aimo, G. Mengozzi, S. Bergui, and G. C. Isaia Short-Term Urine Deoxypyridinoline Biological Variability in the First 5 Years after Menopause Clin. Chem., November 1, 2005; 51(11): 2189 - 2192. [Full Text] [PDF]

				R. L. Fitzgerald, D. J. Hillegonds, D. W. Burton, T. L. Griffin, S. Mullaney, J. S. Vogel, L. J. Deftos, and D. A. Herold 41Ca and Accelerator Mass Spectrometry to Monitor Calcium Metabolism in End Stage Renal Disease Patients Clin. Chem., November 1, 2005; 51(11): 2095 - 2102. [Abstract] [Full Text] [PDF]